futureTEKnow Company Profile

DermaSensor 

DermaSensor uses AI and spectroscopy to help physicians assess suspicious skin lesions for melanoma and other common skin cancers.

Headquarters

Miami, Florida, USA

Year Founded

2009

Top Impacted Industries

Healthcare, Medical Technology, Dermatology, Medical Devices, Primary Care

About Us

DermaSensor develops an AI-powered, non-invasive device that combines Elastic Scattering Spectroscopy and machine learning to evaluate suspicious skin lesions. The handheld system analyzes cellular and subcellular features and provides immediate results to help physicians assess the risk of melanoma, basal cell carcinoma, and squamous cell carcinoma.

Related Articles

Trending Companies

futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.

© 2026 All Rights Reserved.